Published in Cancer Weekly, September 23rd, 2003
"Epithelial scrapes of the cervix from patients with cervix cancer (n=30) and without the diseased condition (n=23) were processed for the micronucleus test," investigators in India report.
"Statistical analysis of the data revealed significantly elevated frequency of micronucleated (MNd) cells in all the patients irrespective of the stage of cancer," wrote G. Gandhi and colleagues, Guru Nanak Developmental University, Department of Human Genetics.
"The damage within the stage-types was, however, not significant," they added.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.